Loading…
Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. (RTSN) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Falls Church, United States and has 12 employees. The company is worth $117.23M. The share price is 6.0% below its 52-week high of $14.97. None of the 38 superinvestors we track reported it in their latest 13F. Over the last 30 days, company insiders bought $369.6K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in RTSN.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| OTLKOutlook Therapeutics, Inc. | $0.49 | — | — | 0.00% | — | $118.85M |
| BGMBGM Group Ltd. | $8.65 | — | 0.1x | 0.00% | -7.41% | $115.51M |
| HUMAHumacyte, Inc. | $0.43 | — | 3.8x | 0.00% | -547.87% | $119.18M |
| VYGRVoyager Therapeutics, Inc. | $1.86 |
| — |
| 0.7x |
| 0.00% |
| -54.09% |
| $114.61M |
| OWLTOwlet, Inc. | $4.11 | — | 5.1x | 0.00% | — | $120.1M |
| SPRBSpruce Biosciences Inc | $39.65 | — | 1.3x | 0.00% | -105.98% | $113.95M |